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Abstract
Background: Antenatal influenza and pertussis vaccination prevent serious disease in mothers and
infants. Aboriginal individuals are at increased risk of infection yet little is known about vaccine
coverage among Aboriginal mothers.
Aims: Estimate the uptake of influenza and pertussis vaccination among pregnant Aboriginal women
in Western Australia and identify barriers and enablers to vaccination.
Materials and Methods: Four hundred Aboriginal women, aged ≥ 18 years, who gave birth to a live
infant between April and October 2015 were randomly selected and invited to participate in telephone
interviews. Of the 387 women who did not decline, 178 had a functioning phone number and 100
completed the survey. Analyses were weighted by maternal residence.
Results: During pregnancy the majority of Aboriginal mothers were recommended influenza 66%
(unweighted, 65/96=68%) and pertussis 65% (unweighted, 62/94=66%) vaccines, with 62%
(unweighted, 56/94=56%) and 63% (unweighted, 60/93=65%) receiving the vaccinations, respectively.
Almost all vaccinated women (98%) reported wanting to protect their baby as the reason for
immunisation. Rural mothers were more likely than metropolitan mothers to have been vaccinated
against influenza (OR 4.1, 95% CI 1.7-10.2) and pertussis (OR 3.1, 95% CI 1.2-7.6). Recommendation
by a healthcare provider was strongly associated with vaccine uptake (influenza: OR 15.6, 95% CI 4.949.5; pertussis: OR 13.3, 95% CI 4.6 -38.0).
Conclusion: Vaccination uptake among Western Australian Aboriginal mothers is comparable with
rates reported for non-Aboriginal populations worldwide. Provider recommendation is the single most
important factor associated with vaccination uptake, underlining the importance of integrating
vaccination into routine antenatal care.

Introduction
Antenatal influenza and pertussis vaccinations are vital public health interventions that prevent serious
diseases in both pregnant mothers and infants under six months of age. Influenza infection during
pregnancy has been associated with adverse maternal and neonatal outcomes, including preterm labour
and delivery, pneumonia, and death.1 Vaccination not only protects mothers against infection during
their pregnancy, but also protects infants during the first months of life via maternal antibodies.
Maternal vaccination has been shown to prevent 63% of laboratory-confirmed infections of influenza
in infants less than six-months-old2 and 91% of infections with Bordetella pertussis in infants younger
than three months.3 Due to the potential health benefits of vaccination during pregnancy, influenza
vaccine has been recommended and funded by the Australian government for all pregnant women,
during any trimester, since 2009.4,5 Antenatal pertussis vaccination was introduced in Western
Australia and most other Australian jurisdictions in April 2015 following the death of a four-week old
baby due to pertussis. Midwives and nurses are authorized by the Department of Health to administer
influenza vaccine to pregnant women in all WA public metropolitan and regional facilities that provide
antenatal care.6

Aboriginal and Torres Straight Islander women (hereafter respectfully referred to as Aboriginal) are at
increased risk of serious infections with influenza compared to non-Aboriginal women, and Aboriginal
children are nearly three times as likely as non-Aboriginal children to be hospitalised with influenza or
pertussis.7 Considering the increased burden of disease for Aboriginal mothers and their children,
ensuring antenatal vaccinations are offered to Aboriginal mothers is a public health priority. Although
several cross-sectional studies have measured vaccine uptake in the community, few studies have
assessed vaccine uptake among Aboriginal mothers. Surveys from Sydney and Melbourne have shown
that vaccine uptake has increased among pregnant women between 2010 and 2014.8,9 However both
studies included small numbers of Aboriginal mothers, eight and nine respectively, and did not include

a subgroup analysis based on Aboriginality. A small pilot study of 58 Aboriginal mothers in
Queensland who were pregnant in 2012 or 2013 found that just nine (17%) had received an influenza
vaccination during their pregnancy.10 A study of influenza vaccination coverage rate in the Northern
Territory pre and post the 2009 H1N1 pandemic found that coverage rates during the pre-pandemic
period were negligible (2%), but showed a substantial increase in vaccine uptake to 41% during the
pandemic period.11 A more recent Northern Territory study reported influenza and pertussis
vaccination coverage in pregnant Aboriginal mothers of 64% and 24%, respectively but did not
examine predictors of antenatal vaccine uptake.12

In Western Australia, annual telephone surveys of mothers have been conducted by the Department of
Health Western Australia (WA Health) since 2012 to monitor antenatal influenza vaccination uptake.13
The current study aimed to evaluate uptake of influenza and pertussis vaccines among Aboriginal
pregnant women in Western Australian and to identify barriers and enablers to acceptance of vaccines
during pregnancy.

Methods and Materials
The research protocol, including the survey instrument, was designed by WA Health’s Communicable
Disease Control Directorate (CDCD) in consultation with WA Health’s Office of Aboriginal Health,
the Aboriginal Health Council of WA and WA Health Consumer Council of Aboriginal Advisory
Program.

A random sample of 400 (46.0% of eligible population) Aboriginal women, aged ≥ 18 years, who gave
birth to a live baby between 05/04/2015 and 04/10/2015 (i.e. were pregnant during the 2015 influenza
season) was selected from the Midwives Notification System (MNS), a legally mandated statewide data
collection of attended births. With an estimated population size of 870, assuming a 40% vaccine

uptake14, a minimum of 112 participants were needed to measure vaccine coverage with a precision of
+/- 8.5% at the standard 95% confidence interval.

Mobile phone numbers were obtained from the MNS and eligible women were sent a text message
informing them about the study and giving them the opportunity to opt out of participation. Women
who declined were not contacted again, the remaining mothers were telephoned in December 2015 by
one of four female Aboriginal interviewers and invited to participate in a 15 to 20-minute computerassisted telephone survey about antenatal influenza and pertussis vaccination during their most recent
pregnancy. At least three attempts at different times of the day were made to reach each participant by
telephone.

The survey instrument was adapted from the Pregnancy Risk Assessment Monitoring Systems survey,
a validated telephone survey of pregnant women conducted by the United States Centers for Disease
Control and Prevention.15 Additionally, co-author and lead interviewer TT developed a cultural guide
for conducting telephone interviews to ensure cultural safety was maintained. The survey included
questions regarding healthcare provider recommended of vaccination during their most recent
pregnancy, whether the woman received a vaccine, and reasons why the woman was or was not
vaccinated. Sociodemographic and medical factors were also collected. For women who self-reported
being vaccinated, consent was obtained to contact their healthcare provider to verify the vaccination
against their health records, for those who consented medical verification of the vaccination event was
attempted.

We analysed data using STATA version 14.1 (StataCorp LP, Texas USA). Among respondents 48% of
women were from metropolitan areas and 52% from rural areas, whereas 36% of Aboriginal women
who gave birth during the same period were from metropolitan areas and 65% from rural areas.

Therefore analyses were weighted by the residence of the mother to adjust for over-representation of
metropolitan women in the survey respondents. Results are reported as weighted percentages in the
first instance with the unweighted raw numbers and percentages included in brackets. Data from
women who answered ‘unsure’ or ‘don’t know’ were excluded from analysis. Variables significant at
α=0.05 in univariate logistic regression analyses were included in a hierarchical multivariate logistic
regression model in order to control for potential confounding factors. The final multivariate regression
model estimated the odds of vaccination, adjusting for socioeconomic status, metropolitan versus rural
residence and recommendation by a healthcare provider. Reasons for or against vaccination for either
influenza or pertussis were compared using Pearson’s chi square analysis.

Ethics approval was obtained from the WA Health Human Research Ethics Committee (#2015/43),
WA Aboriginal Health Ethics Committee (657) and the University of Notre Dame Human Research
Ethics Committee (016060F).

A plain language summary of key research findings was disseminated to all participants and Aboriginal
organisations involved in designing the research protocol.

Results
Of the 400 women invited to participate in the survey, 13 (3%) declined participation, of the remaining
387 women 178 (45.9%) had a functioning phone number. Of these, 100 (56.2%) women participated
in the survey (Figure 1). Reasons for not completing the survey among the 78 women with a working
phone number included the telephone number was not theirs (i.e. it was functional but not correct) and
no answer despite at least three call attempts and leaving messages for calls to be returned.

Participants’ demographic characteristics are shown in Table 1. A total of 66% (95% CI 56-75%)
(unweighted, 65/96=68%) of women reported having been recommended influenza vaccination during
their pregnancy and 62% (95% CI 52-72%) (unweighted, 6/94=60%) stated they had received the
vaccination. A total of 65% (95% CI 55-74%) (unweighted, 62/94=66%) of women reported having
been recommended pertussis vaccination and 63% (95% CI 53-72%) (unweighted, 60/93=65%) stated
they had received the vaccination. Among women who were recommended vaccination during
pregnancy, 85% (unweighted, 49/65=75%) received an influenza vaccine and 86% (unweighted,
49/62=79%) received a pertussis vaccine. Among unvaccinated women, 61% (unweighted,
20/38=53%) stated they would have received an influenza vaccination and 88% (unweighted,
29/33=88%) would have received pertussis had it been recommended by a healthcare provider.

Among women who were vaccinated against influenza, 32% (unweighted, 21/55=38%) received their
vaccine in a general practice (GP), 29% (unweighted, 16/55=29%) in a public hospital antenatal clinic,
25% (unweighted, 12/55=22%) in an Aboriginal Community Controlled Health Organisation
(ACCHO), 9% (unweighted, 3/55=5%) in a community health vaccination clinic, 4% (unweighted,
2/55=4%) in a workplace vaccination clinic and 2% (unweighted, 1/55=2%) in a private hospital
antenatal clinic. Similarly, 39% (unweighted, 26/60=43%) of women received their pertussis
vaccination in a GP, 34% (unweighted, 19/60=32%) in a public hospital antenatal clinic, 18%
(unweighted, 10/60=17%) in an ACCHO, 5% (unweighted, 2/60=3%) in a community vaccination
clinic and 1% (unweighted, 1/60=2%) in a workplace vaccination clinic.

Rural women were more likely to have received their antenatal vaccinations at the health service where
they received their antenatal care, with 44% (n=18/41) of vaccinated women receiving their antenatal
care in a public antenatal clinic and 31% (n=11/36) and 36% (n=12/33) respectively receiving their
influenza and pertussis vaccination as the same location. Similarly 44% (n=18/41) of rural women

received their antenatal care at an ACCHO with 31% (n=11/36) and 24% (n=8/33) receiving their
antenatal influenza and pertussis vaccination there. In contrast 70% (n=19/27) of vaccinated women
living in a metropolitan area received their antenatal care at a public antenatal clinic but only 26%
(n=5/19) and 28% (n=7/19) respectively received their influenza or pertussis vaccination at this
location, while only 15% (n=4/27) received their antenatal care at a GP but 63% (n=12/19) and 60%
(n=15/25), respectively, received their influenza or pertussis vaccination there.

The reasons reported for getting vaccinated or remaining unvaccinated by mother for both influenza
and pertussis were similar (Table 2). The main reasons reported by vaccinated women for receiving
both influenza and pertussis vaccinations was wanting to protect their baby; 97% (unweighted,
54/56=96%) for influenza and 95% (unweighted, 56/60=93%) for pertussis. The reasons for remaining
unvaccinated included not being recommended vaccination, influenza: 49% (unweighted, 17/38=45%)
and pertussis 34% (unweighted, 11/33=33%), and safety concerns regarding both antenatal vaccines.
Safety concerns were more commonly reported for influenza vaccine, with 30% (unweighted,
13/38=34%) of unvaccinated women reporting concern about influenza vaccine causing harm to the
baby compared 26% (unweighted, 9/33=27%) in mothers not vaccinated for pertussis (χ2(1)=8.90,
p=0.003). More women reported they were worried about the side effects of influenza vaccine, 36%
(unweighted, 16/38=42%) compared to pertussis 11% (unweighted, 5/33=15%) vaccine (χ2(1)=2.85,
p=0.091).

Univariate analyses demonstrated that recommendation by a healthcare provider and living in a rural
area were both positively and significantly associated with antenatal influenza or pertussis vaccination
uptake. Being in the middle and least socioeconomically disadvantaged tertile was negatively and
significantly associated with influenza vaccine uptake (Table 3).

Hierarchical weighted multivariate analysis showed that advice by a healthcare providers was the
single most important factor for both influenza (aOR: 12.1, 95%CI 5.1-66.7) and pertussis (aOR: 11.3,
95%CI 3.7-34.5) vaccination uptake after controlling for residence of the mother and socioeconomic
status. Residing in a rural area was an additional independent predictor of antenatal influenza uptake
(aOR: 3.3, 95%CI 1.3-18.4).

Discussion
To our knowledge, this is the first cross-sectional survey of vaccine uptake among Aboriginal mothers
in Western Australia. In this survey, nearly two-thirds of Aboriginal women received an influenza or
pertussis vaccine during her most recent pregnancy. While these vaccination rates are suboptimal,
results are comparable with vaccination rates for non-Aboriginal women in WA14 and pertussis
vaccination uptake was more than double that of Northern Territory Aboriginal women.12,16 In 2015,
the proportion of all pregnant women in WA who received an influenza or pertussis vaccination were
61% and 70%, respectively (unpublished data from WA Health).

Our findings are consistent with Australian8,13,17,18 and international19,20 publications showing that
recommendation by a healthcare provider remains the most important predictor of antenatal vaccination
uptake. Although antenatal influenza vaccination has been a standard part of antenatal practice since
2009, more than one-third of women surveyed report that they had not received a recommendation of
influenza or pertussis vaccination. Based on the responses from women who were not vaccinated, we
estimate the coverage rates of 80% for antenatal influenza and 89% for pertussis vaccination could be
achieved if all mothers had been recommended vaccination. This hypothesis is supported by a Northern
Territory study reporting that the discrepancy between influenza and pertussis vaccination uptake (64%

vs 23%) among pregnant Aboriginal women was probably because annual influenza vaccination is
offered routinely to all Aboriginal adults irrespective of pregnancy status.16

Women whose antenatal care provider does not offer on-site vaccination are required to make and
attend at least one additional appointment to receive their vaccinations, incurring inconvenience and
maybe additional costs. We found that women in the metropolitan area mostly received vaccines from
general practitioners, even if a general practitioner did not provide most of their antenatal care. In
contrast, women residing in rural or remote areas of the State mostly received their vaccination from
their nominated antenatal care provider, and women more commonly reported receiving their
vaccination from an ACCHO. The positive association observed between rural residence and antenatal
vaccination uptake mirrors the situation with childhood vaccinations in WA Aboriginal people21, where
vaccine coverage is greater in rural and remote areas in comparison to metropolitan areas. These results
may reflect variation in health services in the State. Further research that directly addresses health
provider behaviour is needed.

There are a number of limitations that may impact the generalisability of these findings, including a
potential selection bias of study participants. Participation was restricted to women who have access to
a mobile phone and mobile phone reception. These women may also have better access to healthcare
services. We aimed to reduce this bias by adjusting for the disparity in the geographic location of
mothers in the study sample compared to the eligible population by weighting our survey results.
However, this is a broad adjustment and may not have fully accounted for differences in the health of
participants and non-participants. As a result, it is possible that these findings to not generalise to the
entire population of Aboriginal mothers. Because measurement of vaccination status relied on selfreport, results may have been influenced by reporting bias.22 We were able to verify 86% of selfreported vaccinations against available medical records, indicating any bias in estimation is likely to be

small. Furthermore, as no verification was done for mothers who self-reported non-vaccination,
vaccination uptake may have been underestimated in this sample.

Verification of self-reported vaccination status using the Australian Immunisation Register (AIR) or the
WA Midwives Notification System (MNS) data sets was not possible because our study was conducted
in 2015 and vaccination information for adults was not available through the AIR prior to September
2016 and not collected in the MNS before July 2016. Future studies could include verification of selfreported immunisation status against these data sources.

Whilst acknowledging the limitations of the study, these results are the first published which evaluate
the barriers and enablers to antenatal vaccination uptake among Aboriginal women in Australia. Our
study showed that there is no significant difference between Aboriginal women and non-Aboriginal
women in terms of antenatal vaccination uptake and reasons for vaccination or non-vaccination.
Similar to previous studies, recommendation by an antenatal care provider was the single most
important factor associated with vaccination uptake.13 Healthcare providers need to incorporate the
recommendation and delivery of influenza and pertussis vaccination into their routine antenatal care
provision. General practitioners, midwives, Aboriginal health workers and obstetricians will benefit
from up skilling on the current recommendations, administration, documentation and reporting of
antenatal influenza and pertussis vaccination. Offering vaccination at the time of recommendation, as
part of routine antenatal care could be an effective way to increase uptake. Given the high proportion of
Aboriginal women who said they would have been immunised had a healthcare provider recommended
vaccination, acceptance of antenatal vaccination is high among Aboriginal women.

Conclusions

Our results show that two in every three Aboriginal mothers receive an influenza or pertussis vaccine
during pregnancy. While these results are encouraging, given the disproportion burden of vaccinepreventable disease in Aboriginal population, improving the proportion of Aboriginal mothers who
receive an influenza and pertussis vaccine during pregnancy is a priority. Further improvement could
be achieved if providers consistently recommended and offered vaccine to pregnant women. This
would likely have the added benefit of re-enforcing the importance of vaccination among women who
are soon-to-be mothers. Comprehensive recording of antenatal influenza and pertussis vaccinations in
the AIR and midwifery databases would facilitate ongoing monitoring of this important component of
antenatal care.
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Table 1. Demographic characteristics of study participants (unweighted)
Characteristic

N=100
Participants

Age (years):
Range, mean

18-43, 26.3

<20

15

20-29

55

≥ 30

30

Location of residence:
Metro

48

Rural

52

Highest level of education completed:
Primary School

10

High School

64

TAFE

18

Undergraduate University Degree

6

Postgraduate University Degree

2

Socioeconomic Status:
Tertile 3: least disadvantaged

35

Tertile 2

41

Tertile 1: most disadvantaged

24

Chronic Medical Condition:
Yes

25

No

75

Location of Antenatal Care:
Public hospital antenatal clinic

54

Aboriginal Community Controlled Health
Organisation (ACCHO)

24

General practice (GP)

19

Private specialist obstetrician

1

Unsure/ Don’t know

2

Table 2. Reasons given by mothers for receiving an antenatal vaccination or remaining unvaccinated; multiple responses
allowed
Reasons given for vaccination
Influenza

Pertussis

n= 56

n= 60

(n, weighted%)

(n, weighted %)

Wanting to protect their baby

54 (97)

56 (95)

Worried about getting the condition

37 (68)

28 (44)

Midwife recommended vaccination

21 (66)

31 (54)

GP recommended vaccination

37 (62)

29 (48)

Normally receive the influenza vaccination

26 (51)

Not asked

Family member or friend recommended vaccination

25 (50)

22 (40)

An Aboriginal health worker recommended vaccination

24 (48)

20 (39)

An Obstetrician had recommended it

12 (24)

11 (21)

I have a chronic medical condition

6 (11)

0 (0)

Reasons given for remaining unvaccinated
Influenza

Pertussis

n= 38

n= 33

Not recommended vaccination

17 (49)

11 (35)

Worried about the side effects of the vaccination

16 (36)

5 (12)

Concerns about the vaccination causing harm to the baby

13 (30)

9 (26)

Don’t normally get the vaccination

7 (21)

Not asked

Not applicable

4 (22)

Advised against vaccination by a health care worker

5 (12)

2 (7)

Advised against vaccination by family or friends

4 (8)

2 (6)

Baby was born too early

Table 3. Univariate analysis with receiving antenatal influenza or pertussis vaccine as the dependent variable
Influenza
Number

Odds Ratio†

Pertussis
P Value†

95% CI†

Number

Vaccinated

Vaccinated

n/N

n/N

(weighted %)

(weighted %)

Odds Ratio†

P Value†

95% CI†

49/62 (85)

15.6

P<0.001

4.9-49.5

49/61 (86)

13.3

P<0.001

4.6-37.9

37/50 (76)

4.1

P=0.002

1.7-10.2

35/47 (79)

3.1

P=0.015

1.2-7.6

20-29 years

31/53 (63)

0.4

P >0.05

0.1-1.5

34/51 (73)

1.2

P >0.05

0.8-6.8

30-43 years

14/26 (60)

0.3

P >0.05

0.1-1.5

17/27 (65)

0.8

P >0.05

0.3-4.2

Recommended Vaccination by
health care provider*
Rural residence*
Age

0.2-3.4
9/21 (53)

0.5

P >0.05

0.2-1.5

13/23 (63)

0.6

P >0.05

0.2-1.8

High School

36/62 (66)

1.2

P >0.05

0.3-5.9

38/58 (74)

1.0

P >0.05

0.2-5.6

TAFE

8/16 (57)

0.9

P >0.05

0.1-5.3

9/18 (53)

0.4

P >0.05

0.1-2.7

Undergraduate degree

5/6 (87)

4.3

P >0.05

0.3-59.3

5/6 (87)

2.5

P >0.05

0.2-36.9

Postgraduate degree

2/2 (100)

1

1/2 (60)

0.6

P >0.05

0.0-13.8

Mother has a chronic disease
Level of education

Location of antenatal care

Public Hospital

30/51 (66)

0.8

Private Obstetrician

1/1 (100)

1

GP

9/18 (55)

0.5

ACCHO

15/22 (72)

1- most disadvantaged

P >0.05

32/51 (68)

0.8

0/1 (0)

1

13/19 (74)

1.1

1

14/20 (73)

1

18/22 (86)

1

15/20 (85)

1

2

22/38 (57)

0.2

P= 0.034

0.1-0.9

24/38 (62)

0.3

P >0.05

0.1-1.0

3- least disadvantaged

16/34 (52)

0.2

P= 0.017

0.0-0.7

21/35 (66)

0.3

P >0.05

0.1-1.2

P >0.05

0.2-2.5

0.1-2.0

P >0.05

0.2-2.6

P >0.05

0.2-4.3

Socioeconomic Tertile*

* Statistically significant at P ≤ 0.05
†

Weighted analysis

